These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34978145)

  • 1. Accumulation of high molecular weight kininogen in the brains of Alzheimer's disease patients may affect microglial function by altering phagocytosis and lysosomal cathepsin activity.
    Zamolodchikov D; Duffield M; Macdonald LE; Alessandri-Haber N
    Alzheimers Dement; 2022 Oct; 18(10):1919-1929. PubMed ID: 34978145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial control of microglial phagocytosis by the translocator protein and hexokinase 2 in Alzheimer's disease.
    Fairley LH; Lai KO; Wong JH; Chong WJ; Vincent AS; D'Agostino G; Wu X; Naik RR; Jayaraman A; Langley SR; Ruedl C; Barron AM
    Proc Natl Acad Sci U S A; 2023 Feb; 120(8):e2209177120. PubMed ID: 36787364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An antibody against HK blocks Alzheimer's disease peptide β-amyloid-induced bradykinin release in human plasma.
    Chen ZL; Singh P; Wong J; Horn K; Strickland S; Norris EH
    Proc Natl Acad Sci U S A; 2019 Nov; 116(46):22921-22923. PubMed ID: 31659032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stress Granules Modulate SYK to Cause Microglial Cell Dysfunction in Alzheimer's Disease.
    Ghosh S; Geahlen RL
    EBioMedicine; 2015 Nov; 2(11):1785-98. PubMed ID: 26870803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse Bone Marrow-derived Microglia-like Cells Secrete Transforming Growth Factor-β1 and Promote Microglial Aβ Phagocytosis and Reduction of Brain Aβ.
    Kuroda E; Nishimura K; Kawanishi S; Sueyoshi M; Ueno F; Toji Y; Abo N; Konishi T; Harada K; Satake S; Shima C; Toda Y; Kitamura Y; Shimohama S; Ashihara E; Takata K
    Neuroscience; 2020 Jul; 438():217-228. PubMed ID: 32522344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microglial autophagy is impaired by prolonged exposure to β-amyloid peptides: evidence from experimental models and Alzheimer's disease patients.
    Pomilio C; Gorojod RM; Riudavets M; Vinuesa A; Presa J; Gregosa A; Bentivegna M; Alaimo A; Alcon SP; Sevlever G; Kotler ML; Beauquis J; Saravia F
    Geroscience; 2020 Apr; 42(2):613-632. PubMed ID: 31975051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deacetylation of TFEB promotes fibrillar Aβ degradation by upregulating lysosomal biogenesis in microglia.
    Bao J; Zheng L; Zhang Q; Li X; Zhang X; Li Z; Bai X; Zhang Z; Huo W; Zhao X; Shang S; Wang Q; Zhang C; Ji J
    Protein Cell; 2016 Jun; 7(6):417-33. PubMed ID: 27209302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of methylation-regulated genes modulating microglial phagocytosis in hyperhomocysteinemia-exacerbated Alzheimer's disease.
    Wang X; Liu L; Jiang X; Saredy J; Xi H; Cueto R; Sigler D; Khan M; Wu S; Ji Y; Snyder NW; Hu W; Yang X; Wang H
    Alzheimers Res Ther; 2023 Oct; 15(1):164. PubMed ID: 37789414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of Amyloid Burden by Proliferated Homeostatic Microglia in
    Shin JH; Hwang YS; Jung BK; Seo SH; Ham DW; Shin EH
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33803262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High molecular mass kininogen inhibits cathepsin G-induced platelet activation by forming a complex with cathepsin G.
    Selim TE; Ghoneim HR; Abdel Ghaffar HA; Colman RW; Dela Cadena RA
    Hematol J; 2001; 2(6):371-7. PubMed ID: 11920276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microglial amyloid beta clearance is driven by PIEZO1 channels.
    Jäntti H; Sitnikova V; Ishchenko Y; Shakirzyanova A; Giudice L; Ugidos IF; Gómez-Budia M; Korvenlaita N; Ohtonen S; Belaya I; Fazaludeen F; Mikhailov N; Gotkiewicz M; Ketola K; Lehtonen Š; Koistinaho J; Kanninen KM; Hernández D; Pébay A; Giugno R; Korhonen P; Giniatullin R; Malm T
    J Neuroinflammation; 2022 Jun; 19(1):147. PubMed ID: 35706029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TLQP-21 mediated activation of microglial BV2 cells promotes clearance of extracellular fibril amyloid-β.
    Cho K; Jang YJ; Lee SJ; Jeon YN; Shim YL; Lee JY; Lim DS; Kim DH; Yoon SY
    Biochem Biophys Res Commun; 2020 Apr; 524(3):764-771. PubMed ID: 32037089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gossypetin ameliorates 5xFAD spatial learning and memory through enhanced phagocytosis against Aβ.
    Jo KW; Lee D; Cha DG; Oh E; Choi YH; Kim S; Park ES; Kim JK; Kim KT
    Alzheimers Res Ther; 2022 Oct; 14(1):158. PubMed ID: 36271414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of high mobility group protein-1 (HMG1) in amyloid-beta homeostasis.
    Takata K; Kitamura Y; Kakimura J; Shibagaki K; Tsuchiya D; Taniguchi T; Smith MA; Perry G; Shimohama S
    Biochem Biophys Res Commun; 2003 Feb; 301(3):699-703. PubMed ID: 12565837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha7 nicotinic acetylcholine receptor-specific agonist DMXBA (GTS-21) attenuates Aβ accumulation through suppression of neuronal γ-secretase activity and promotion of microglial amyloid-β phagocytosis and ameliorates cognitive impairment in a mouse model of Alzheimer's disease.
    Takata K; Amamiya T; Mizoguchi H; Kawanishi S; Kuroda E; Kitamura R; Ito A; Saito Y; Tawa M; Nagasawa T; Okamoto H; Sugino Y; Takegami S; Kitade T; Toda Y; Kem WR; Kitamura Y; Shimohama S; Ashihara E
    Neurobiol Aging; 2018 Feb; 62():197-209. PubMed ID: 29175709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic regulation of microglial phagocytosis: Implications for Alzheimer's disease therapeutics.
    Lepiarz-Raba I; Gbadamosi I; Florea R; Paolicelli RC; Jawaid A
    Transl Neurodegener; 2023 Oct; 12(1):48. PubMed ID: 37908010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cromolyn Reduces Levels of the Alzheimer's Disease-Associated Amyloid β-Protein by Promoting Microglial Phagocytosis.
    Zhang C; Griciuc A; Hudry E; Wan Y; Quinti L; Ward J; Forte AM; Shen X; Ran C; Elmaleh DR; Tanzi RE
    Sci Rep; 2018 Jan; 8(1):1144. PubMed ID: 29348604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nogo receptor impairs the clearance of fibril amyloid-β by microglia and accelerates Alzheimer's-like disease progression.
    Wang J; Qin X; Sun H; He M; Lv Q; Gao C; He X; Liao H
    Aging Cell; 2021 Dec; 20(12):e13515. PubMed ID: 34821024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential Alzheimer's disease drug targets identified through microglial biology research.
    Lepiarz-Raba I; Hidayat T; Hannan AJ; Jawaid A
    Expert Opin Drug Discov; 2024 May; 19(5):587-602. PubMed ID: 38590098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.